Related Experiment Videos
[Therapy of erectile dysfunction using papaverine--2 1/2 years' experience]
M Schnyder von Wartensee1, A Sieber, U E Studer
1Urologische Universitätsklinik, Inselspital, Bern.
Schweizerische Medizinische Wochenschrift
|July 30, 1988
Summary
Intracavernous papaverine injections can restore erectile function. Self-injection therapy offers significant success rates for men seeking treatment for erectile dysfunction.
Area of Science:
- Physiology
- Pharmacology
Context:
- Erectile dysfunction (ED) management
- Intracavernous pharmacotherapy
Purpose:
- Discuss the physiological basis of erectile function.
- Evaluate the efficacy and limitations of intracavernous papaverine therapy for ED.
- Highlight the importance of patient self-injection for treatment success.
Summary:
- Papaverine, administered via intracavernous injection, is a viable treatment option for erectile dysfunction.
- Self-administration of papaverine injections empowers patients and improves treatment outcomes.
- Approximately 20% of patients regained natural potency after initiating self-injection therapy.
- An additional 40% utilized self-injections as a sustained, long-term management strategy for ED.
Impact:
- Empowers patients with a manageable at-home treatment option for erectile dysfunction.
- Demonstrates the potential for significant recovery of erectile function through consistent self-administered therapy.
- Provides a framework for understanding the practical application and long-term benefits of intracavernous papaverine in ED treatment.